HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination strategies.

AbstractAIM:
To investigate the possible relationship between serum levels and avidities of antibodies against tetanus toxoid (TT) and Haemophilus influenzae type b (Hib) in children that were vaccinated after treatment for childhood acute lymphoblastic leukaemia (ALL).
METHODS:
The study groups were 31 paediatric patients with ALL and 18 healthy controls. All subjects were vaccinated with TT and a protein conjugated Hib vaccine. Antibody levels were analysed at three time points: At diagnosis of ALL, after cessation of treatment before vaccination and three weeks after vaccination. Avidity was measured twice, with a thiocyanate elution assay, at diagnosis of ALL and three weeks after vaccination.
RESULTS:
There was a correlation between level and avidity of tetanus antibodies after vaccination (r(s) = 0.59, P < 0.001). In the standard-risk and intermediate-risk ALL groups, all patients responded with protective levels of tetanus antibodies with normal avidity. In the high-risk ALL group 7/9 patients had subprotective levels of tetanus antibodies after vaccination and concomitantly the lowest avidity, implying poor protection against tetanus. No patients were found with low levels and low avidity of anti-Hib IgG, and 29/31 patients had full protection after a single dose of conjugated Hib-vaccine.
CONCLUSION:
The vaccination strategy after childhood ALL must be different for low-risk and high-risk ALL groups, since the high-risk group fail to elicit a recall response to tetanus.
AuthorsTorben Ek, Lotta Mellander, Mirjana Hahn-Zoric, Jonas Abrahamsson
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 95 Issue 6 Pg. 701-6 (Jun 2006) ISSN: 0803-5253 [Print] Norway
PMID16754551 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Haemophilus Vaccines
  • Haemophilus influenzae type b polysaccharide vaccine
  • Polysaccharides, Bacterial
  • Tetanus Toxoid
Topics
  • Adolescent
  • Adult
  • Antibodies, Bacterial (immunology)
  • Antibody Affinity
  • Bacterial Capsules
  • Child
  • Child, Preschool
  • Haemophilus Vaccines (immunology)
  • Haemophilus influenzae (immunology)
  • Humans
  • Polysaccharides, Bacterial (immunology)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (immunology)
  • Tetanus Toxoid (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: